Minneapolis, Minn., June 20, 2016 – Pharmacogenomics company OneOme is pleased to announce key business milestones in advance of launching its RightMed test.
The RightMed test is a cost-effective, comprehensive, personalized pharmacogenomic analysis of 22 genes provided at the point of care. The t...
MINNEAPOLIS, March 17, 2016 /PRNewswire/ — OneOme, LLC, a pharmacogenomics company, announced today the hiring of Dr. Justin Odegaard, M.D., Ph.D. and Ross Higgins to manage and lead their pharmacogenomics testing laboratory. Both Dr. Odegaard and Mr. Higgins bring extensive background in laborato...
The Wall Street Journal published an article explaining the benefits of pharmacogenomic testing. Pharmacogenomics identifies which inherited genetic variations a person has and predicts how an individual will — or will not — respond to specific medications.
Because everyone responds to drugs di...
MINNEAPOLIS, Minnesota—OneOme, LLC, a pharmacogenomics company, announced today that it will move its corporate office and clinical laboratory to the Highlight Center in northeast Minneapolis in early 2016. The new location will expand OneOme’s operations with a high-throughput clinical laborato...
MINNEAPOLIS, Minnesota—OneOme, LLC, a pharmacogenomics company, recently announced that it appointed Paul Owen as its Chief Operating Officer.
Troy Kopischke, CEO, stated: “Owen’s experience and expertise in pharmacogenomics are incredible assets for OneOme. His leadership will drive OneOme...
